Global Artificial Heart Market Professional Survey Report 2019

Artificial hearts are being used to help patients with total heart failure live normal lives past their life expectancy time line, or to help patients survive until their transplant date either by replacing the heart completely or by replacing the ventricles. The device is surgically implanted in the chest in order to help in the functioning of a deteriorating heart. An artificial heart may also be used temporarily and is removed once the heart starts functioning normally. In cases where the damage is severe, the biological heart is completely replaced with the artificial heart. An artificial heart is powered by either compressed air or electricity.
The rise in the number of cardiac disorders along with an increase in the geriatric population is anticipated to drive the artificial heart market in the coming years. Improper lifestyle, leading to deteriorating cardiac condition is expected to offer growth opportunities during the forecast period for the manufacturers of artificial heart.
North America is expected to contribute to the largest share in the artificial heart market in the coming years, due to technological advancements as well as improved treatment of cardiac conditions in United States and Canada. Asia Pacific is expected to record substantial demand for artificial heart market during the forecast period, due to the rise in geriatric population in various Asian countries.

The global Artificial Heart market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Artificial Heart volume and value at global level, regional level and company level. From a global perspective, this report represents overall Artificial Heart market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Artificial Heart in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Artificial Heart manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
SynCardia Systems
BiVACOR
CARMAT
Abbott
Cleveland Heart
AbioMed
Jarvik Heart
MyLVAD
Cirtec Medical Systems
Thoratec Corporation

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Ventricular Assist Device (VAD)
Total Artificial Heart

Segment by Application
Hospitals
Clinics
Others

Frequently Asked Questions